Home › Funds › Spruce Street Capital LP › ANRO

Spruce Street Capital LP position in ANRO

ALTO NEUROSCIENCE INC · Health Care

Spruce Street Capital LP reported holding 1,676,558 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$42.8M, representing 6.81% of its reported portfolio and ranking #4 among its reported holdings. Spruce Street Capital LP has disclosed ANRO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.68M sh
Reported value held$42.80M
Portfolio Weight6.81%
First reportedQ4 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's ANRO position evolved

Spruce Street Capital LP first disclosed a stake in ANRO in Q4 2025 at 222,844 shares (US$4.0M). The position peaked in Q3 2026 at 1,676,558 shares, worth US$42.8M. Across 4 filings, Spruce Street Capital LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,676,558 shares valued at US$42.8M — an increase of 323,511 shares quarter over quarter.. Notable position changes include a 495% increase in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 222.84K $3.97M New
Q1 2026 1.33M $29.12M Add
Q2 2026 1.35M $35.71M Add
Q3 2026 1.68M $42.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 62 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$94.7M), Commodore Capital LP (US$71.9M), PERCEPTIVE ADVISORS LLC (US$42.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Spruce Street Capital LP held ANRO?

Spruce Street Capital LP has disclosed ANRO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Spruce Street Capital LP's current position in ANRO?

As of Q3 2026, Spruce Street Capital LP holds 1.68M shares of ANRO (ALTO NEUROSCIENCE INC), valued at $42.80M, representing 6.81% of its reported portfolio and ranking #4.

Has Spruce Street Capital LP been buying or selling ANRO?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP increased its position in ANRO. The position peaked in Q3 2026 at 1.68M shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.